Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents
Author:
Funder
Double First Class University Plan
National Major Science and Technology Projects of China
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference39 articles.
1. Repurposing drugs as inhaled therapies in asthma;Anderson;Adv. Drug Deliv. Rev.,2018
2. Establishment of pseudovirus infection mouse models for in vivo pharmacodynamics evaluation of filovirus entry inhibitors;Chen;Acta Pharm. Sin. B,2018
3. Unraveling the molecular mechanism of traditional Chinese medicine: formulas against acute airway viral infections as examples;Eng;Molecules,2019
4. Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches;Gioia;Biochem. Pharmacol.,2020
5. Comprehensive screening and identification of natural inducible nitric oxide synthase inhibitors from Radix Ophiopogonis by off-line multi-hyphenated analyses;Guo;J. Chromatogr. A,2019
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and Safety of Lianhua Qingke Tablets in the Treatment of Long Coronavirus Disease (COVID) Cough: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study;Engineering;2024-09
2. A ternary correlation multi‐symptom network strategy based on in vivo chemical profile identification and metabolomics to explore the molecular basis of Ephedra herb against viral pneumonia;Journal of Separation Science;2024-05-31
3. Comparison of Non-ephedrine Constituents from <i>Ephedra</i> Plants Cultivated in Japan;Chemical and Pharmaceutical Bulletin;2024-04-17
4. iNGNN-DTI: prediction of drug–target interaction with interpretable nested graph neural network and pretrained molecule models;Bioinformatics;2024-03-01
5. Natural products as a source of Coronavirus entry inhibitors;Frontiers in Cellular and Infection Microbiology;2024-02-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3